Prophylactic Mastectomy for BRCA Mutation Carriers After Ovarian Cancer Treatment: Is It Beneficial?

Expert Review of Anticancer Therapy - United Kingdom
doi 10.1080/14737140.2018.1424547
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

BRCA Mutation Carriers Show Normal Ovarian Response in in Vitro Fertilization Cycles

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2015English

Prostate Cancer Screening in BRCA and Lynch Syndrome Mutation Carriers

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
Medicine
2013English

It Is Not All About BRCA: Cullin-Ring Ubiquitin Ligases in Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2014English

UK BRCA Mutation Testing in Patients With Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2015English

Acceptability of Prophylactic Salpingectomy With Delayed Oophorectomy as Risk-Reducing Surgery Among BRCA Mutation Carriers

Gynecologic Oncology
GynecologyOncologyObstetrics
2014English

Cancer Screening and Prevention in BRCA Mutation Carriers: A Missed Opportunity?

British Journal of Cancer
Cancer ResearchOncology
2019English

Trial of Prophylactic Mastectomy Is Needed

BMJ
1999English

BRCA Mutations in the Manifestation and Treatment of Ovarian Cancer

Oncotarget
Oncology
2017English

Colorectal Cancer Prognosis: Is It All Mutation, Mutation, Mutation?

Gut
Gastroenterology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy